GILLIS JONATHAN 4
4 · MapLight Therapeutics, Inc. · Filed Jul 20, 2026
Research Summary
AI-generated summary of this filing
MapLight (MPLT) CAO/Interim CFO Jonathan Gillis Sells Shares
What Happened
Jonathan Gillis, MapLight Therapeutics' Chief Accounting Officer and Interim CFO, disposed of 36,979 shares in a series of open‑market sales between July 15–17, 2026, generating total gross proceeds of approximately $1,372,667. Individual transactions ranged from ~600 to 16,969 shares at weighted average prices between $36.13 and $38.17 per share. Several of the sales were routine—some were mandated to cover tax withholding on vested restricted stock units and at least one sale was executed under a pre‑existing 10b5‑1 trading plan.
Key Details
- Filing date: July 20, 2026. Reported transaction dates: July 15–17, 2026. (Timeliness not indicated in the provided data.)
- Aggregate sold: 36,979 shares for approx. $1,372,667 total.
- Transaction breakdown (date — shares — weighted avg price — proceeds — footnote):
- 2026-07-15 — 5,356 sh @ $36.13 — $193,512 (F1/F2)
- 2026-07-15 — 4,699 sh @ $36.94 — $173,581 (F4)
- 2026-07-16 — 6,979 sh @ $36.66 — $255,850 (F3)
- 2026-07-16 — 1,476 sh @ $37.44 — $55,261 (F5)
- 2026-07-17 — 600 sh @ $36.51 — $21,906 (F7)
- 2026-07-17 — 16,969 sh @ $37.61 — $638,204 (F8; includes a 10b5‑1 plan reference F6)
- 2026-07-17 — 900 sh @ $38.17 — $34,353 (F9)
- Shares owned after the transactions: not reported in the provided filing data.
- Notable footnotes:
- F1: Certain sales were "sell‑to‑cover" to satisfy statutory tax withholding on vested RSUs (not discretionary).
- F6: At least one transaction was made pursuant to a Rule 10b5‑1 trading plan adopted Dec 26, 2025.
- F2–F5, F7–F9: Prices reported are weighted averages; each footnote lists the price ranges for multiple executions and the filer offers to provide per‑trade details on request.
Context
These transactions are sales (not purchases). Sell‑to‑cover transactions are routine and required for tax withholding on RSU vesting and do not necessarily indicate a change in sentiment. A 10b5‑1 plan sale means that at least some transactions were pre‑planned. For retail investors, purchases typically carry more informational weight than routine disposals; this filing documents multiple orderly sales rather than an acquisition or option exercise.
Insider Transaction Report
Form 4
GILLIS JONATHAN
CAO and Interim CFO
Transactions
- Sale
Voting Common Stock
[F1][F2]2026-07-15$36.13/sh−5,356$193,512→ 175,863 total - Sale
Voting Common Stock
[F1][F3]2026-07-15$36.94/sh−4,699$173,581→ 171,164 total - Sale
Voting Common Stock
[F1][F4]2026-07-16$36.66/sh−6,979$255,850→ 164,185 total - Sale
Voting Common Stock
[F1][F5]2026-07-16$37.44/sh−1,476$55,261→ 162,709 total - Sale
Voting Common Stock
[F6][F7]2026-07-17$36.51/sh−600$21,906→ 162,109 total - Sale
Voting Common Stock
[F6][F8]2026-07-17$37.61/sh−16,969$638,204→ 145,140 total - Sale
Voting Common Stock
[F6][F9]2026-07-17$38.17/sh−900$34,353→ 144,240 total
Footnotes (9)
- [F1]Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.68 to $36.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.68 to $37.325 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.12 to $37.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.26 to $37.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.91 to $36.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.37 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Kristopher L. Hanson, Attorney-in-Fact|2026-07-20